ClinVar Miner

Submissions for variant NM_001849.4(COL6A2):c.2197G>A (p.Gly733Arg)

gnomAD frequency: 0.00001  dbSNP: rs886042922
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000337022 SCV000337415 uncertain significance not provided 2018-01-19 criteria provided, single submitter clinical testing
Ambry Genetics RCV001265687 SCV001443854 uncertain significance Inborn genetic diseases 2019-01-04 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001303665 SCV001492916 pathogenic Bethlem myopathy 1A 2023-09-26 criteria provided, single submitter clinical testing This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 733 of the COL6A2 protein (p.Gly733Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant COL6A2-related conditions (PMID: 30564623, 34167565). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 284693). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL6A2 protein function. For these reasons, this variant has been classified as Pathogenic.
CeGaT Center for Human Genetics Tuebingen RCV000337022 SCV001747335 uncertain significance not provided 2021-06-01 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000337022 SCV003832530 uncertain significance not provided 2023-01-05 criteria provided, single submitter clinical testing
GeneDx RCV000337022 SCV005376416 uncertain significance not provided 2024-04-17 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33441455, 30564623, 34167565)
Division of Human Genetics, Children's Hospital of Philadelphia RCV000477924 SCV000536776 uncertain significance Bethlem myopathy 1A; Ullrich congenital muscular dystrophy 1A; Myosclerosis 2015-06-20 no assertion criteria provided research
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000337022 SCV001809096 uncertain significance not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000337022 SCV001956182 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.